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Primary care
Impaired glucose tolerance: qualitative and quantitative
study of general practitioners’ knowledge and perceptions
Graeme Wylie, A Pali S Hungin, Joanne Neely
Abstract
Objective To investigate general practitioners’
knowledge of and attitudes to impaired glucose
tolerance.
Design Mixed methodology qualitative and
quantitative study with semistructured interviews,
focus groups, and questionnaires.
Setting 34 general practitioners in five primary care
groups in the north east of England.
Results All the general practitioners had knowledge
of impaired glucose tolerance as a clinical entity, but
they had little awareness of the clinical significance of
impaired glucose tolerance and were uncertain about
managing and following up these patients. Attitudes
to screening were mixed and were associated with
reservations about increased workload, concern about
lack of resources, and pessimism about the
effectiveness of lifestyle interventions. Some general
practitioners felt strongly that screening patients for
impaired glucose tolerance and subsequent lifestyle
intervention medicalised an essentially social problem
and that a health educational approach, involving
schools and the media, should be adopted instead.
A minority expressed a positive attitude towards a
pharmacological approach.
Conclusion Awareness of impaired glucose tolerance
needs to be raised, and guidelines for management
are needed. General practitioners remain to be
convinced that they have a role in attempting to
reduce the incidence of type 2 diabetes by targeting
interventions at patients with impaired glucose
tolerance.
Introduction
Type 2 diabetes is a serious condition, with implications
for the mortality, morbidity, and social functioning of
patients. The prevalence of type 2 diabetes is
increasing, and the number of patients in the United
Kingdom is expected to rise from just over one million
in 1997 to just under three million by 2010.1 This will
inevitably be reflected in rising costs. An estimated
7›8% of the total NHS budget is spent on patients with
type 2 diabetes,2 and the burden of caring for these
patients is falling increasingly on primary care.3 4
Impaired glucose tolerance, typically characterised
by hyperglycaemia and insulin resistance, is considered
to be a stage in the development of type 2 diabetes. Up
to half of all people with impaired glucose tolerance
will progress to type 2 diabetes within 10 years of diag›
nosis.5 In addition, people with impaired glucose toler›
ance are known to be at significantly increased risk of
cardiovascular disease, which may present before the
onset of diabetes.6 Studies in the United Kingdom have
reported the prevalence of impaired glucose tolerance
in the 35›65 year age group to be around 17%.7
Increasing evidence indicates that intervention can
favourably influence the clinical course of impaired
glucose tolerance,8–10 with some studies showing a 58%
reduction in progression to diabetes.11 12 However,
information is lacking on British general practitioners’
awareness of the clinical significance of impaired
glucose tolerance and their current management of
these patients. This study aimed to ascertain levels of
awareness among general practitioners of the preva›
lence and clinical significance of impaired glucose tol›
erance and to explore their attitudes to its detection
and management.
Methods
Participants and setting
Focus groups
We used stratified random sampling (to give a
representative male:female ratio from each primary
care group) to recruit participants for the focus groups.
We chose general practitioners from lists supplied by
Derwentside, Sunderland West, South Tyneside, and
Gateshead West and Central Primary Care Groups. We
initially contacted potential participants by telephone
and then invited them by letter to take part. We
contacted 56 general practitioners, of whom 28 agreed
to participate; two of these failed to attend. The
remaining 26 general practitioners (18 men, eight
women) participated in four focus groups (three
groups of seven participants and one group of five
participants). The mean age of participants was 44
(range 30›58) years; all were principals, with a mean of
11 (1›27) years’ experience in general practice. The 30
general practitioners who either declined or failed to
attend were similar in terms of sex and practice charac›
teristics. The table shows the characteristics of
individual participants.
Participants received an honorarium of £50.00. We
held two focus groups in district general hospital post›
graduate centres, one in a general practitioner surgery,
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and one in the Centre for Health Studies, Durham
University. The average duration of focus groups was
75 minutes.
Semistructured interviews
We chose the eight participants (six men, two women)
in the semistructured interviews purposively13 from a
list of all general practitioners in one health authority.
All were principals, with a mean age of 41 (31›46) years
and an average of 12 (4›24) years’ experience in
general practice. Participants were chosen to reflect
diversity in terms of age, sex, practice characteristics
(list size, geographical location), and involvement in
diabetes care (little involvement, lead general prac›
titioner, clinical assistant in diabetes, primary care
group adviser on diabetes) (table). All general
practitioners invited agreed to take part. We conducted
the interviews at participants’ surgeries, and interviews
had an average duration of 35 minutes. Participants
received an honorarium of £25.00.
Collection and analysis of data
The lead investigator (GW) carried out all the focus
groups and interviews, which were audiotaped for later
transcription. Before each focus group, participants
completed a questionnaire designed to evaluate their
knowledge of the clinical significance and prevalence
of impaired glucose tolerance. Their responses were
then explored in the focus group discussion. The lead
investigator then gave a short presentation, based on a
review of the literature, on the anticipated rise in
prevalence of type 2 diabetes, together with the clinical
significance, prevalence, and management of impaired
glucose tolerance.1 2 5–11 Further focus group discussion
centred around participants’ attitudes to impaired glu›
cose tolerance in the light of what, for most of them,
was new knowledge.
We took a similar approach with the semistruc›
tured interviews, administering the questionnaire
verbally and following this with open ended questions
concerning knowledge of the clinical significance and
prevalence of impaired glucose tolerance. We then
gave a short presentation, as above, and used
subsequent open ended questions to explore attitudes
to and perceptions of the detection and management
of impaired glucose tolerance.
We used a “pragmatic variant” grounded theory
approach to analyse the data by generating categories
and themes.14 15 GW and APSH coded the data
independently to increase the reliability of the study.
We adopted an iterative approach to data analysis, with
analysis beginning after the first focus groups and
interviews, to allow emerging themes to be explored in
subsequent interviews. The coders agreed that no new
themes were emerging after four focus groups and
eight semistructured interviews, and saturation was
achieved.15
Characteristics of participants in focus groups (coded FGnx) and semistructured interviews (coded INTn)
Code Age (years) Sex
Employment
status
Years in
practice
Size of
practice
list No of partners Practice area Role in diabetes
FG1a 58 Male Full time 25 1 950 1 Suburban Lead general practitioner
FG1b 41 Female Full time 15 12 300 6 Semirural Little involvement
FG1c 37 Male Full time 5 20 000 9 Urban Little involvement
FG4d 48 Female Full time 5 3 100 2 Semirural Little involvement
FG1e 50 Male Full time 14 4 200 2 Suburban Equal role with others
FG1f 44 Male Full time 13 3 750 2 Semirural Equal role with others
FG1g 52 Male Full time 27 2 300 1 Rural Lead general practitioner
FG2a 37 Male Full time 4 12 200 5 Suburban Primary care group adviser
FG2b 50 Female Part time 11 8 700 6 Suburban District diabetes advisory group
FG2c 44 Male Full time 2 4 500 2 Urban Lead general practitioner
FG2d 36 Male Part time 4 8 000 4 Semirural Little involvement
FG2e 55 Male Full time 25 6 100 3 Urban Lead general practitioner
FG3a 40 Male Full time 12 5 000 3 Urban Equal role with others
FG3b 47 Male Full time 18 3 000 1 Urban Lead general practitioner
FG3c 37 Male Full time 7 10 000 4 Urban Lead general practitioner
FG3d 53 Male Full time 14 8 500 3 Urban Little involvement
FG3e 36 Female Part time 1 6 500 4 Suburban Little involvement
FG3f 42 Female Full time 11 11 500 7 Suburban Lead general practitioner
FG4g 44 Male Full time 20 5 000 3 Urban Little involvement
FG4a 34 Female Part time 3 11 000 7 Urban Little involvement
FG4b 45 Female Full time 16 9 800 6 Urban Little involvement
FG4c 30 Female Full time 1 7 100 4 Suburban Little involvement
FG4d 40 Male Full time 2 2 700 1 Suburban Lead general practitioner
FG4e 54 Male Full time 20 3 400 1 Suburban Lead general practitioner
FG4f 37 Male Full time 7 8 400 4 Semirural Lead general practitioner
FG4g 42 Male Full time 14 2 000 1 Semirural Lead general practitioner
INT1 31 Male Full time 4 8 500 5 Suburban Little involvement
INT2 51 Male Full time 24 15 000 6 Urban Lead general practitioner
INT3 46 Female Part time 14 15 000 8 Suburban Clinical assistant
INT4 36 Male Full time 6 2 150 1 Semirural Lead general practitioner
INT5 46 Male Full time 15 23 000 12 Semirural Equal role with others
INT6 42 Male Full time 15 20 000 9 Suburban Lead general practitioner
INT7 42 Male Full time 13 9 800 4 Semirural Primary care group adviser
INT8 34 Female Part time 6 7 200 5 Rural Little involvement
Primary care
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Validation
To increase confidence in the validity of the findings,
we sent all 34 participants a report summarising the
outcomes of the study. Twenty eight (82%) replied stat›
ing that they “strongly agreed” (10 respondents) or
“agreed” (18) that the report was a true representation
of their opinions.
Results
Questionnaires—All participants were aware of impaired
glucose tolerance as a clinical entity. However, 16 (47%)
participants were unaware of the risk of impaired glu›
cose tolerance progressing to type 2 diabetes, and 21
(62%) were unaware of the increased risk of cardiovas›
cular disease. In addition, 17 (50%) participants had no
idea how many patients with impaired glucose
tolerance might be known to their practice, and 13
(38%) estimated prevalence at less than 1% (figure).
Focus groups and interviews—Three main themes
emerged from data collected before participants
received a presentation detailing the anticipated rise in
prevalence of type 2 diabetes, together with the clinical
significance, prevalence, and management of impaired
glucose tolerance (box 1). Eight main themes emerged
after the presentation (box 2).
Discussion
The aim of this study was to investigate general practi›
tioners’ knowledge of the prevalence and clinical
significance of impaired glucose tolerance and their
attitudes to its detection and management. The results
indicate that awareness of the existence of impaired
glucose tolerance was good but that awareness of the
prevalence and clinical significance of impaired
glucose tolerance was poor. In addition, general practi›
tioners seem to be uncertain about how best to
manage and follow up these patients. This has implica›
tions for the training and education of general
practitioners, and not least for patient care in a field
that is likely to expand exponentially in the next few
years.
The study also indicates that only a small
proportion of patients with impaired glucose tolerance
are currently known to practices and that general prac›
titioners are reluctant to pursue more aggressive case
finding and management, even after being presented
with a critical appraisal of the literature. Several factors
seem to contribute to this unwillingness to screen and
intervene in this condition. General practitioners were
afraid of being overwhelmed by the workload
generated, admitting to reluctance to divert finite
resources away from other clinical areas, and were pes›
simistic about the effectiveness of lifestyle intervention.
Furthermore, some felt strongly that screening patients
for impaired glucose tolerance and subsequent lifestyle
intervention would medicalise an essentially social
problem and that a health educational approach,
involving schools and the media, should be adopted
instead. Other studies have shown that general
practitioners lack confidence in their ability to change
lifestyle behaviour and suggested that the solution
would be to increase training and support.16 17 Pill et al
have shown how difficult it is for primary healthcare
professionals to change patients’ behaviour in the con›
text of type 2 diabetes.18 Our findings are in broad
agreement with those of Lawlor et al, who found that
general practitioners were in favour of measures to
tackle social and environmental determinants of ill
health.19
Conversely, some of the general practitioners in
this study expressed a positive attitude towards
pharmacological intervention in patients with
impaired glucose tolerance, even though the effective›
ness of this has yet to be shown in large scale clinical
trials. This may be because of the perception that phar›
macological intervention is ultimately likely to be more
effective than lifestyle intervention. However, it could
also be argued that the act of prescribing drugs for
these patients essentially defines impaired glucose tol›
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General practitioners’ estimation of the number of patients known to
have impaired glucose tolerance in their practice
Box 1: Main themes from data collected before
participants received evidence based
presentation on impaired glucose tolerance
Low awareness of the prevalence and clinical
significance of impaired glucose tolerance
“I would have no idea . . . I mean, as I say I think . . .
I doubt if we have very many that have been formally
identified” (INT1)
“Perhaps 2%?” (INT8)
“. . . probably a lot of our colleagues are pretty ignorant
about the implications of impaired glucose tolerance”
(FG3f)
Uncertainty about managing patients with impaired
glucose tolerance
“There’s the book of guidelines; is there one [a
guideline for management of patients with impaired
glucose tolerance] in there?” (INT5)
“I must say, we don’t repeat their glucose tolerance test
. . . they might get a sugar level done” (FG2c)
“I don’t honestly have a . . . a . . . plan for what we would
do” (INT1)
Support for a guideline for managing impaired
glucose tolerance
“Of course, it would be excellent if we had a guideline
to follow” (FG1g)
“Yeah, I think the more that you have guidelines the
more that actually these sort of things can be passed
over to the nurses and to people who are actually
probably much better than we are at monitoring these
things” (FG1e)
“There should be guidelines for us to have . . . and a
greater ability to follow so that those patients who
come up that we think we can succeed with . . . we can
have a proper plan of action” (FG4f)
Primary care
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Box 2: Main themes from data collected after participants received evidence based presentation on
impaired glucose tolerance
Fear of being overwhelmed by the workload involved in screening and managing patients with impaired glucose
tolerance
“I think we all probably fight shy of diagnosing too many people with impaired glucose tolerance, I mean, I’m sure we
all do it. I mean, I occasionally get people who’ve had a borderline high sugar and it gets passed to the nurse for
dietary intervention . . . they don’t all have a glucose tolerance test; the reason for that is it involves a whole lot of
workload” (FG3c)
[“So there’s a resistance from the profession because of the workload implications, is that what you’re saying?”] “Yes,
basically” (FG2d)
“Who wants to find someone you’ve got to treat and measure their blood every so often?” (FG3d)
Concern that widespread screening and management of patients with impaired glucose tolerance would be
impossible without extra resources
“The practices simply can’t be taking all the load. I think there are huge resource implications for the practices
involved. Certainly there is a huge disincentive at the moment for me to find any more patients because I can’t afford
to treat them” (FG1a)
“But our role shouldn’t be to intervene unless we’ve got the resources to do it . . . we’ve done that before, and we just
pay lip service to it” (FG4b)
“It would be very difficult with the present staffing . . . I think it would be very difficult. We would have to have
additional resources to do it” (INT2)
Concern at diverting finite resources from other clinical areas
“. . . why should we be doing that when we haven’t even . . . when we’re not even treating the ones that have got it [type
2 diabetes] properly yet?” (INT6)
“Fine, yes, in theory [we could screen for impaired glucose tolerance], but we haven’t only even got diabetes to look
after . . . but you’ve got so many things to look after and outside issues as well, so where does it stop?” (FG1e)
“ [I wonder] where the money’s going to come from to perhaps employ new staff and that sort of thing. There are
barriers on a health authority scale—it’s going to be, it might mean a shift of resource towards one thing rather than
something else” (INT8)
Pessimism regarding the effectiveness of lifestyle intervention
“. . . we have diabetics who . . . who just totally ignore the advice you give them, and I think going further back than that
and giving them advice when they haven’t got diabetes as such is going to be very difficult” (INT4)
“Around here, I just wonder how effective lifestyle advice is going to be” (INT6)
“. . . trying to persuade them [patients with type 2 diabetes] to make any changes at all in their behaviour just makes
my heart plummet . . . the initiative [giving lifestyle advice to patients with impaired glucose tolerance] coming from
us, I think, is doomed to failure (FG3e)
Positive attitudes towards pharmacological intervention in patients with impaired glucose tolerance
“Well, even that [lifestyle intervention] is a tall order for a lot of them. I just feel as though, if you’re going to do this,
you’ve really got to put them on metformin. I mean that’s what’s happened with our [CHD patients] . . . I mean we
started off with exercise, diet and that kind of thing, stopping smoking, and now, I mean we’ve substituted that with
statins, atenolol, and lisinopril . . . I think it shouldn’t be too expensive; metformin presumably is a comparatively cheap
drug” (FG2c)
“More than happy, I mean we . . . we’re starting to come on board with this as a group . . . a high risk group that . . . um
. . . sort of an aggressive treatment is the only way to possibly, to make any difference. So yes, I would be happy to
prescribe” (INT7)
“I think if I had impaired glucose tolerance I would take the metformin to delay the diabetes” (FG4g)
Uncertainty regarding the role of general practitioners in detecting and treating impaired glucose tolerance
“I think it’s our job to educate people and give them the information and let them make the choice. I think the people
who are motivated, who are in control of their own lives, will take that advice and act on it and then the rest of the
people will just carry on until something bad happens” (FG2d)
“I think we’ve got a role in that [detecting and lifestyle intervention for impaired glucose tolerance] to some degree,
but I don’t think it’s educating everybody in town and sort of leading their lives for them” (FG1f)
“But that’s not my job, you know; I’m a GP and I’m actually there probably not to do a lot of prevention but to actually
do a little bit of tinkering with the people already ill” (FG4f)
Concern that screening and treating impaired glucose tolerance medicalises an essentially social problem
“It’s a society cop out; we’re always trying to medicalise things, and it’s the same as, you know, I think, the current vogue
for medicalising teenage pregnancy . . . and under age smoking and everything else” (INT5)
“. . . these [preventing chronic disease] are all kind of social things, and throughout history what we have to accept, as
doctors, is that we have a very minimal impact on the health of society” (FG4f)
“I think it’s on a bigger scale than us having to prevent it [type 2 diabetes] right at the end of the line. It’s like us
preventing suicides when there’s unemployment and stress” (FG3e)
Positive attitudes towards a health educational approach
“I think improvements could be made with people with glucose tolerance if they are educated about glucose
intolerance at school; if they could have fruit at school instead of hamburgers and chips they probably . . . and
therefore the change has to start from school up and the responsibility of educating I think should be put on to
schools” (FG1a)
“If all schools had free fruit and free healthy living, free exercise . . . then in 20›30 years’ time I suspect the impact of
that would be enormous” (FG4d)
“I think health promotion must have a huge responsibility—they have a huge budget . . . I mean, hundreds of
thousands of pounds go into health promotion. Why can’t they organise themselves and, if needs be, set up
opportunistic screening at supermarkets . . . to prevent people coming out with the wrong things in their baskets”
(FG1g)
Primary care
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erance as a medical problem, and general practitioners
have been shown to be more comfortable managing
illness than preventing disease.20
The general practitioners who participated in this
study broadly supported the provision of a guideline for
the management of patients with impaired glucose
tolerance in primary care, but we were unable to find any
suitable published guideline. This has implications for
guideline development. General practitioners have posi›
tive attitudes towards the use of guidelines,21 although
problems exist with regard to implementation.22
Methodological considerations
The rigour of this study was increased by triangula›
tion,23 both of methods and analysis, and by validation
by respondents. However, few data were available on
the 30 out of 64 general practitioners who either
declined or failed to participate. Although sex and size
of partnership were broadly similar, we had no way of
knowing if the knowledge and attitudes of these
general practitioners differed from those participating
in the study. In addition, we cannot exclude the
possibility that the personal and intellectual bias of the
lead investigator (GW) may have shaped the data. This
has been minimised by making the account as reflexive
as possible and by reporting a wide range of different
perspectives, a method described by Mays and Pope as
“fair dealing.”23 Factors relating to the ethnic origin of
patients did not emerge as a theme from our data. Two
out of eight general practitioners interviewed were of
Asian ethnic origin, and each focus group contained
one or two such participants. The population
prevalence of patients of Asian ethnic origin in the
study area is low (0.3% for County Durham, 0.5% for
Gateshead and South Tyneside, and 0.6% for
Sunderland, compared with 3.3% for England and
Wales24). This may limit the generalisability of our study
to areas with large ethnic minority populations.
Conclusions
The recently published Diabetes National Service Frame›
work: Standards document recommends that the NHS
and partner organisations adopt both a “population”
approach (tackling obesity and sedentary lifestyles)
and a “targeted” approach (identifying and intervening
in high risk groups, such as patients with impaired glu›
cose tolerance) to reducing the incidence of type 2
diabetes.25 The national service framework recognises
that such interventions are also likely to have an impact
on reducing cardiovascular disease. Similarly, early
treatment of macrovascular risk factors may be more
important than screening for and treating asympto›
matic type 2 diabetes itself.26 Although studies from
other countries have shown encouraging results,11 12
questions about the feasibility of primary prevention of
type 2 diabetes in the United Kingdom remain
unanswered. Our findings clearly show that general
practitioners have major reservations about the appro›
priateness and effectiveness of giving lifestyle advice to
patients in this context. Similarly, we have shown that
general practitioners perceive the need for consider›
able extra resources if they are to be given the task of
screening for impaired glucose tolerance and interven›
ing in patients at high risk of progression to type 2
diabetes. This has important implications, both for the
implementation of the diabetes national service frame›
work and for primary care research.
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